Imugene Director's Shareholding Adjustment
Imugene Limited (AU:IMU) has released an update. Imugene Limited has announced a change in the holdings of director Paul Hopper, with a disposal of...
Source: biztoc.com
Paul Hopper News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Paul Hopper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Paul Hopper Today - Breaking & Trending Today
Dr Boreham's Crucible: Imugene - FNArena.com
Tim Boreham highlights the prospects for cancer treatment biotech Imugene
Source: fnarena.com
RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer
SYDNEY, Australia, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce it has been granted Human Research Ethics Committee (HREC) approval to commence its First-In-Human Phase I study in Australia for the Company’s therapy for patients with PDL1-positive non-small cell lung cancer (NSCLC). The dose escalation trial of RAD204, which targets PDL1-p
Source: yahoo.com
Imugene raises A$18.2 million in SPP for acquisition of Azer-cel licensing rights
Imugene Ltd (ASX:IMU, OTC:IUGNF) has concluded a strongly supported share purchase plan (SPP), raising A$18.2 million to support its acquisition of...
Source: proactiveinvestors.com.au
Imugene raising $65 million to fund global growth, acquire Azer-cel
Sydney-headquartered Imugene (ASX: IMU) has made a strong start to a $65 million capital raising aimed at supporting its global growth plans.
Source: smallcaps.com.au